The Procter & Gamble Company (PG) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Available-for-sale Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 38.69B USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Available-for-sale Securities, Current |
| Customer receivables | 6.06B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 8.17B USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $38.69B | (m) | (m) | $6.06B | $8.17B | (m) |
| 2026-03-31 | (m) | $38.23B | (m) | (m) | $6.32B | $7.85B | (m) |
| 2025-12-31 | (m) | $36.70B | (m) | (m) | $6.28B | $7.82B | (m) |
| 2025-09-30 | (m) | $37.99B | (m) | (m) | $6.49B | $7.85B | (m) |
| 2025-06-30 | (m) | $36.06B | (m) | (m) | $6.18B | $7.55B | (m) |
| 2025-03-31 | (m) | $34.25B | (m) | (m) | $6.14B | $7.40B | (m) |
| 2024-12-31 | (m) | $33.80B | (m) | (m) | $6.23B | $7.02B | (m) |
| 2024-09-30 | (m) | $36.42B | (m) | (m) | $6.31B | $7.29B | (m) |
| 2024-06-30 | (m) | $33.63B | (m) | (m) | $6.12B | $7.02B | (m) |
| 2024-03-31 | (m) | $32.34B | (m) | (m) | $6.12B | $7.08B | (m) |
| 2023-12-31 | (m) | $35.95B | (m) | (m) | $6.33B | $7.15B | (m) |
| 2023-09-30 | (m) | $37.16B | (m) | (m) | $6.21B | $7.12B | (m) |
| 2023-06-30 | (m) | $35.76B | (m) | (m) | $5.47B | $7.07B | (m) |
| 2023-03-31 | (m) | $38.03B | (m) | (m) | $5.47B | $7.48B | (m) |
| 2022-12-31 | (m) | $38.75B | (m) | (m) | $5.77B | $7.54B | (m) |
| 2022-09-30 | (m) | $36.62B | (m) | (m) | $5.72B | $7.59B | (m) |
| 2022-06-30 | (m) | $33.08B | (m) | (m) | $5.14B | $6.92B | (m) |
| 2022-03-31 | (m) | $34.40B | (m) | (m) | $5.51B | $7.10B | (m) |
| 2021-12-31 | (m) | $38.03B | (m) | (m) | $5.24B | $6.67B | (m) |
| 2021-09-30 | (m) | $36.59B | (m) | (m) | $5.66B | $6.31B | (m) |
| 2021-06-30 | (m) | $33.13B | (m) | (m) | $4.72B | $5.98B | (m) |
| 2021-03-31 | (m) | $32.02B | (m) | (m) | $4.86B | $6.00B | (m) |
| 2020-12-31 | (m) | $31.74B | (m) | (m) | $4.82B | $5.96B | (m) |
| 2020-09-30 | (m) | $30.01B | (m) | (m) | $5.04B | $5.71B | (m) |
| 2020-06-30 | (m) | $32.98B | (m) | (m) | $4.18B | $5.50B | (m) |
| 2020-03-31 | (m) | $32.90B | (m) | $0.00 | $4.64B | $5.33B | (m) |
| 2019-12-31 | (m) | $30.16B | (m) | $0.00 | $5.20B | $5.52B | (m) |
| 2019-09-30 | $14.45B | $30.25B | $9.30B | $0.00 | $5.14B | $5.46B | 0.48× |
| 2019-06-30 | (m) | $30.01B | $4.24B | (m) | $4.95B | $5.02B | (m) |
| 2019-03-31 | $15.02B | $28.37B | $2.74B | $7.08B | $5.20B | $5.36B | 0.53× |
| 2018-12-31 | $17.17B | $31.25B | $3.70B | $8.42B | $5.05B | $5.28B | 0.55× |
| 2018-09-30 | $16.29B | $29.22B | $2.54B | $8.71B | $5.04B | $5.18B | 0.56× |
| 2018-06-30 | (m) | $28.24B | $2.57B | (m) | $4.69B | $4.74B | (m) |
| 2018-03-31 | $20.68B | $30.71B | $5.33B | $10.21B | $5.15B | $5.21B | 0.67× |
| 2017-12-31 | $23.94B | $33.11B | $7.43B | $11.33B | $5.18B | $5.13B | 0.72× |
| 2017-09-30 | $20.95B | $30.72B | $5.02B | $10.98B | $4.94B | $5.02B | 0.68× |
| 2017-06-30 | (m) | $30.21B | $5.57B | (m) | $4.59B | $4.62B | (m) |
| 2017-03-31 | $18.68B | $29.08B | $5.82B | $8.51B | $4.36B | $4.75B | 0.64× |
| 2016-12-31 | $18.18B | $28.89B | $6.05B | $7.40B | $4.73B | $4.79B | 0.63× |
| 2016-09-30 | $18.78B | $32.40B | $7.46B | $6.62B | $4.71B | $5.00B | 0.58× |
| 2016-06-30 | (m) | $30.77B | $7.10B | (m) | $4.37B | $4.72B | (m) |
| 2016-03-31 | $18.41B | $31.36B | $7.89B | $5.92B | $4.59B | $4.96B | 0.59× |
| 2015-12-31 | $19.00B | $32.05B | $9.40B | $4.87B | $4.72B | $5.13B | 0.59× |
| 2015-09-30 | $17.33B | $31.57B | $7.71B | $4.90B | $4.72B | $5.24B | 0.55× |
| 2015-06-30 | (m) | $29.79B | $6.84B | (m) | $4.86B | $5.45B | (m) |
| 2015-03-31 | $18.15B | $31.88B | $8.37B | $4.79B | $4.99B | $5.89B | 0.57× |
| 2014-12-31 | $18.05B | $34.15B | $8.20B | $4.05B | $5.80B | $6.48B | 0.53× |
| 2014-09-30 | $17.04B | $32.07B | $7.49B | $3.36B | $6.20B | $7.10B | 0.53× |
| 2014-06-30 | (m) | $33.73B | $8.56B | (m) | $6.39B | $6.76B | (m) |
| 2014-03-31 | $16.11B | $32.12B | $8.18B | $1.57B | $6.35B | $7.23B | 0.50× |
| 2013-12-31 | $15.41B | $30.73B | $6.93B | $1.57B | $6.91B | $7.38B | 0.50× |
| 2013-09-30 | $14.26B | $33.22B | $6.12B | $1.58B | $6.55B | $7.39B | 0.43× |
| 2013-06-30 | (m) | $30.04B | $5.95B | (m) | $6.51B | $6.91B | (m) |
| 2013-03-31 | (m) | $27.41B | $5.88B | (m) | $6.67B | $7.24B | (m) |
| 2012-12-31 | (m) | $26.23B | $6.64B | (m) | $7.18B | $7.22B | (m) |
| 2012-09-30 | (m) | $24.90B | $5.30B | (m) | $6.99B | $7.33B | (m) |
| 2012-06-30 | (m) | $24.91B | $4.44B | (m) | $6.07B | $6.72B | (m) |
| 2012-03-31 | (m) | $26.90B | $3.99B | (m) | $6.20B | $7.24B | (m) |
| 2011-12-31 | (m) | $29.79B | $4.41B | (m) | $6.91B | $7.44B | (m) |
| 2011-09-30 | (m) | $27.97B | $3.58B | (m) | $6.58B | $8.00B | (m) |
| 2011-06-30 | (m) | $27.29B | $2.77B | (m) | $6.28B | $7.38B | (m) |
| 2011-03-31 | (m) | $26.18B | $2.95B | (m) | $6.26B | $7.62B | (m) |
| 2010-12-31 | (m) | $27.24B | $3.25B | (m) | $6.55B | $7.42B | (m) |
| 2010-09-30 | (m) | $27.64B | $2.60B | (m) | $6.08B | $7.28B | (m) |
| 2010-06-30 | (m) | $24.28B | $2.88B | (m) | $5.33B | $6.38B | (m) |
| 2010-03-31 | (m) | $23.27B | $4.90B | (m) | $5.86B | $6.75B | (m) |
| 2009-12-31 | (m) | $23.68B | $4.13B | (m) | $6.54B | $6.86B | (m) |
| 2009-09-30 | (m) | $28.67B | $6.29B | (m) | $6.24B | $7.05B | (m) |
| 2009-06-30 | (m) | $30.90B | $4.78B | (m) | $5.84B | $6.88B | (m) |
| 2009-03-31 | (m) | (m) | $4.43B | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $5.65B | (m) | (m) | (m) | (m) |
| 2008-09-30 | (m) | (m) | $4.50B | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | $3.31B | (m) | (m) | (m) | (m) |
| 2007-06-30 | (m) | (m) | $5.35B | (m) | (m) | (m) | (m) |
| 2006-06-30 | (m) | (m) | $6.69B | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |